JP6532460B2 - 患者モニタリングシステムに関する臨床規則及び規定のコンピュータ化及び視覚化 - Google Patents
患者モニタリングシステムに関する臨床規則及び規定のコンピュータ化及び視覚化 Download PDFInfo
- Publication number
- JP6532460B2 JP6532460B2 JP2016528623A JP2016528623A JP6532460B2 JP 6532460 B2 JP6532460 B2 JP 6532460B2 JP 2016528623 A JP2016528623 A JP 2016528623A JP 2016528623 A JP2016528623 A JP 2016528623A JP 6532460 B2 JP6532460 B2 JP 6532460B2
- Authority
- JP
- Japan
- Prior art keywords
- staging
- aki
- evaluation
- patient
- guideline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012544 monitoring process Methods 0.000 title claims description 29
- 238000012800 visualization Methods 0.000 title 1
- 201000011040 acute kidney failure Diseases 0.000 claims description 155
- 208000033626 Renal failure acute Diseases 0.000 claims description 142
- 208000009304 Acute Kidney Injury Diseases 0.000 claims description 138
- 238000011156 evaluation Methods 0.000 claims description 67
- 201000010099 disease Diseases 0.000 claims description 44
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 44
- 238000000034 method Methods 0.000 claims description 29
- 210000002966 serum Anatomy 0.000 claims description 24
- 206010007559 Cardiac failure congestive Diseases 0.000 claims description 23
- 210000004369 blood Anatomy 0.000 claims description 22
- 239000008280 blood Substances 0.000 claims description 22
- 238000012545 processing Methods 0.000 claims description 22
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 claims description 21
- 206010019280 Heart failures Diseases 0.000 claims description 18
- 206010001053 acute respiratory failure Diseases 0.000 claims description 17
- 201000004193 respiratory failure Diseases 0.000 claims description 17
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 14
- 238000001514 detection method Methods 0.000 claims description 13
- 210000002700 urine Anatomy 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 8
- 229940109239 creatinine Drugs 0.000 claims description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 108020001621 Natriuretic Peptide Proteins 0.000 claims description 6
- 102000004571 Natriuretic peptide Human genes 0.000 claims description 6
- 239000000692 natriuretic peptide Substances 0.000 claims description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 6
- 210000000265 leukocyte Anatomy 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 5
- 238000004820 blood count Methods 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 230000001419 dependent effect Effects 0.000 claims description 2
- 210000004072 lung Anatomy 0.000 claims description 2
- 230000037396 body weight Effects 0.000 claims 1
- 206010024378 leukocytosis Diseases 0.000 claims 1
- 230000008569 process Effects 0.000 description 22
- 238000012360 testing method Methods 0.000 description 14
- 210000003734 kidney Anatomy 0.000 description 11
- 238000013459 approach Methods 0.000 description 7
- 238000009534 blood test Methods 0.000 description 7
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 description 6
- 108010008064 pro-brain natriuretic peptide (1-76) Proteins 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 238000012959 renal replacement therapy Methods 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 206010040047 Sepsis Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000020832 chronic kidney disease Diseases 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 2
- 206010053159 Organ failure Diseases 0.000 description 2
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 2
- 206010000891 acute myocardial infarction Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000004789 organ system Anatomy 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000005227 renal system Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Data Mining & Analysis (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Bioethics (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361858801P | 2013-07-26 | 2013-07-26 | |
| US61/858,801 | 2013-07-26 | ||
| PCT/IB2014/062967 WO2015011592A2 (en) | 2013-07-26 | 2014-07-09 | Computerization and visualization of clinical rules and definitions for patient monitoring systems. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016528973A JP2016528973A (ja) | 2016-09-23 |
| JP2016528973A5 JP2016528973A5 (https=) | 2017-08-10 |
| JP6532460B2 true JP6532460B2 (ja) | 2019-06-19 |
Family
ID=51492397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016528623A Expired - Fee Related JP6532460B2 (ja) | 2013-07-26 | 2014-07-09 | 患者モニタリングシステムに関する臨床規則及び規定のコンピュータ化及び視覚化 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20160147958A1 (https=) |
| EP (1) | EP3025263A2 (https=) |
| JP (1) | JP6532460B2 (https=) |
| CN (1) | CN105408905A (https=) |
| WO (1) | WO2015011592A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160267223A1 (en) * | 2015-03-10 | 2016-09-15 | Practice Fusion, Inc. | Integrated health data analysis system |
| WO2017210377A1 (en) * | 2016-06-02 | 2017-12-07 | Cardiac Pacemakers, Inc. | Acute kidney injury detection system and methods |
| CN110462744A (zh) * | 2017-03-10 | 2019-11-15 | 皇家飞利浦有限公司 | 具有在视觉上强大的患者状况显示的患者状况监测器 |
| WO2019020497A1 (en) * | 2017-07-25 | 2019-01-31 | Koninklijke Philips N.V. | PRESENTATION CONTEXTUALIZED SPECIFIC TO PATIENT OF PREDICTION SCORE INFORMATION |
| WO2021205033A1 (en) * | 2020-04-10 | 2021-10-14 | Koninklijke Philips N.V. | Clinically meaningful and personalized disease progression monitoring incorporating established disease staging definitions |
| CN114420231B (zh) * | 2022-01-14 | 2024-04-19 | 东南大学 | 一种可解释的急性肾损伤持续预警方法、系统、存储介质及电子设备 |
| EP4312221A1 (en) * | 2022-07-25 | 2024-01-31 | F. Hoffmann-La Roche AG | Consolidation and prioritization of patient critical notifications |
| CN116898444B (zh) * | 2023-08-10 | 2024-06-18 | 上海迎智正能文化发展有限公司 | 一种基于情绪识别的智能监护方法及系统 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5592664A (en) * | 1991-07-29 | 1997-01-07 | Borland International Inc. | Database server system with methods for alerting clients of occurrence of database server events of interest to the clients |
| US5262944A (en) * | 1992-05-15 | 1993-11-16 | Hewlett-Packard Company | Method for use of color and selective highlighting to indicate patient critical events in a centralized patient monitoring system |
| EP1349491B1 (en) * | 2000-12-07 | 2013-04-17 | Children's Medical Center Corporation | Automated interpretive medical care system |
| GB2389290B (en) * | 2002-05-31 | 2005-11-23 | Qinetiq Ltd | Data analysis system |
| WO2005000095A2 (en) * | 2003-06-20 | 2005-01-06 | Mayo Foundation For Medical Education And Research | Isoforms of brain natriuretic peptide |
| KR20070052781A (ko) * | 2004-09-08 | 2007-05-22 | 앨러티스 메디칼 에이에스 | 센서 |
| JP2006180979A (ja) * | 2004-12-27 | 2006-07-13 | Nippon Koden Corp | 複数患者のアラーム情報表示方法および装置 |
| CN101366032A (zh) * | 2005-11-10 | 2009-02-11 | 皇家飞利浦电子股份有限公司 | 用于医疗信息系统的基于决策的显示 |
| JP2010530056A (ja) * | 2007-02-21 | 2010-09-02 | シー・アール・バード・インコーポレーテッド | 腎臓モニター |
| DE102007010834A1 (de) * | 2007-03-03 | 2008-09-04 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung von Herzinsuffizienz für NYHA I Patienten |
| US9585562B2 (en) * | 2008-12-03 | 2017-03-07 | Carefusion 303, Inc. | Method and apparatus for automatically integrating a medical device into a medical facility network |
| EA201290106A1 (ru) * | 2009-09-18 | 2012-12-28 | Астьют Медикал, Инк. | Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности |
| US20110071850A1 (en) * | 2009-09-23 | 2011-03-24 | General Electric Company | Method and system for managing healthcare resources |
| CA2775921C (en) * | 2009-10-08 | 2017-11-21 | The Regents Of The University Of Michigan | Real-time visual alert display |
| WO2011084470A1 (en) * | 2009-12-15 | 2011-07-14 | Mycare,Llc | Health care device and systems and methods for using the same |
| EP2583237A4 (en) * | 2010-06-20 | 2017-02-15 | Univfy, Inc. | Method of delivering decision support systems (dss) and electronic health records (ehr) for reproductive care, pre-conceptive care, fertility treatments, and other health conditions |
| WO2012033771A2 (en) * | 2010-09-07 | 2012-03-15 | The Board Of Trustees Of The Leland Stanford Junior University | Medical scoring systems and methods |
| JP2012159356A (ja) * | 2011-01-31 | 2012-08-23 | Mochida Pharmaceut Co Ltd | 敗血症診断用組合せマーカー |
| US20130024205A1 (en) * | 2011-07-18 | 2013-01-24 | International Business Machines Corporation | Dynamically updating electronic medical records and leveraging a person's path in a facility to mitgate risks |
-
2014
- 2014-07-09 EP EP14759306.5A patent/EP3025263A2/en not_active Ceased
- 2014-07-09 JP JP2016528623A patent/JP6532460B2/ja not_active Expired - Fee Related
- 2014-07-09 CN CN201480042194.XA patent/CN105408905A/zh active Pending
- 2014-07-09 US US14/905,050 patent/US20160147958A1/en not_active Abandoned
- 2014-07-09 WO PCT/IB2014/062967 patent/WO2015011592A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016528973A (ja) | 2016-09-23 |
| US20160147958A1 (en) | 2016-05-26 |
| WO2015011592A3 (en) | 2015-08-06 |
| EP3025263A2 (en) | 2016-06-01 |
| CN105408905A (zh) | 2016-03-16 |
| WO2015011592A2 (en) | 2015-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6532460B2 (ja) | 患者モニタリングシステムに関する臨床規則及び規定のコンピュータ化及び視覚化 | |
| US11961621B2 (en) | Predicting intensive care transfers and other unforeseen events using machine learning | |
| RU2629799C2 (ru) | Оценка и наблюдение острого повреждения легких (ali)/синдрома острой дыхательной недостаточности (ards) | |
| Le et al. | Supervised machine learning for the early prediction of acute respiratory distress syndrome (ARDS) | |
| Pellathy et al. | Intensive care unit scoring systems | |
| McCoy et al. | Reducing patient mortality, length of stay and readmissions through machine learning-based sepsis prediction in the emergency department, intensive care unit and hospital floor units | |
| Bonafide et al. | Development of heart and respiratory rate percentile curves for hospitalized children | |
| CN101203172B (zh) | 测量瞬时患者急性值的设备 | |
| Shah et al. | Emergency department sepsis screening tool decreases time to antibiotics in patients with sepsis | |
| Aakre et al. | Prospective validation of a near real-time EHR-integrated automated SOFA score calculator | |
| US20090149724A1 (en) | System and method for predicting septic shock | |
| Sepanski et al. | Designing a pediatric severe sepsis screening tool | |
| US20110077968A1 (en) | Graphically representing physiology components of an acute physiological score (aps) | |
| US11197642B2 (en) | Systems and methods of advanced warning for clinical deterioration in patients | |
| CN101938939A (zh) | 用于测量和预测患者呼吸稳定性的装置 | |
| Collins et al. | “Reading Between the Lines” of Flowsheet Data: Nurses' Optional Documentation Associated with Cardiac Arrest Outcomes | |
| Agor et al. | The value of missing information in severity of illness score development | |
| KR102310888B1 (ko) | 사망 위험도에 대한 정보 제공 방법 및 이를 이용한 디바이스 | |
| Sarlabous et al. | Development and validation of a sample entropy-based method to identify complex patient-ventilator interactions during mechanical ventilation | |
| Henry et al. | A FHIR-enabled streaming sepsis prediction system for ICUs | |
| US20180004901A1 (en) | Systems and methods for holistic analysis of medical conditions | |
| Evangelou et al. | Clinical Connections: Identifying validated nursing quality indicators for the intensive care unit: an integrative review | |
| IQBAL | Correlation analysis of vital signs to monitor disease risks in ubiquitous healthcare system | |
| Hunter et al. | INFORM: integrated support for decisions and activities in intensive care | |
| Tang et al. | Why is a rule-based shock early warning system not accurate: a case study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20170214 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170629 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170629 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180531 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180612 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180911 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181206 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190509 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190521 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6532460 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |